Exact Mass: 715.2206058

Exact Mass Matches: 715.2206058

Found 26 metabolites which its exact mass value is equals to given mass value 715.2206058, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

ADP-Ribosyl-L-arginine

2-amino-5-[(E)-[amino({5-[({[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl}amino)methylidene]amino]pentanoic acid

C21H35N9O15P2 (715.1727780000001)


ADP-Ribosyl-L-arginine is the substrate of the protein ADP-ribosylarginine hydrolase (EC-Number 3.2.2.19 ), removing ADP-ribose from arginine residues in ADP ribosylated proteins. Arginine residues in proteins act as acceptors, catalyzing the NAD (+)-dependent activation of the enzyme adenylate cyclase (EC 4.6.1.1). (MetaCyc) [HMDB] ADP-Ribosyl-L-arginine is the substrate of the protein ADP-ribosylarginine hydrolase (EC-Number 3.2.2.19 ), removing ADP-ribose from arginine residues in ADP ribosylated proteins. Arginine residues in proteins act as acceptors, catalyzing the NAD (+)-dependent activation of the enzyme adenylate cyclase (EC 4.6.1.1). (MetaCyc).

   
   

(1R,2S,3S,4S,5S,6R,7R,9S,10R)-2,6-diacetoxy-1,9-dibenzoyloxy-3-nicotinoyloxy-4-hydroxydihydro-beta-agarofuran

(1R,2S,3S,4S,5S,6R,7R,9S,10R)-2,6-diacetoxy-1,9-dibenzoyloxy-3-nicotinoyloxy-4-hydroxydihydro-beta-agarofuran

C39H41NO12 (715.2628626000001)


   

(1R,2S,3S,4S,5R,7S,8S,9R,10R)-2,3-diacetoxy-8,9-dibenzoyloxy-1-nicotinoyloxy-4-hydroxydihydro-beta-agarofuran

(1R,2S,3S,4S,5R,7S,8S,9R,10R)-2,3-diacetoxy-8,9-dibenzoyloxy-1-nicotinoyloxy-4-hydroxydihydro-beta-agarofuran

C39H41NO12 (715.2628626000001)


   

(1R,2S,3S,4S,5R,7S,8S,9R,10R)-2,8-diacetoxy-3,9-dibenzoyloxy-1-nicotinoyloxy-4-hydroxydihydro-beta-agarofuran

(1R,2S,3S,4S,5R,7S,8S,9R,10R)-2,8-diacetoxy-3,9-dibenzoyloxy-1-nicotinoyloxy-4-hydroxydihydro-beta-agarofuran

C39H41NO12 (715.2628626000001)


   
   

acetonitrile,cyclohexa-1,3-dien-1-yl-[(4R,5R)-5-[hydroxy(diphenyl)methyl]-2,2-dimethyl-1,3-dioxolan-4-yl]-phenylmethanol,dichlorotitanium,1,2-dimethoxyethane

acetonitrile,cyclohexa-1,3-dien-1-yl-[(4R,5R)-5-[hydroxy(diphenyl)methyl]-2,2-dimethyl-1,3-dioxolan-4-yl]-phenylmethanol,dichlorotitanium,1,2-dimethoxyethane

C37H43Cl2NO6Ti (715.1946747999999)


   

Neladenoson dalanate

Neladenoson bialanate

C35H34ClN7O4S2 (715.1802114000001)


C78274 - Agent Affecting Cardiovascular System

   

(2S)-2-amino-5-[[amino-[[(3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-3,4-dihydroxyoxolan-2-yl]amino]methylidene]amino]pentanoic acid

(2S)-2-amino-5-[[amino-[[(3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-3,4-dihydroxyoxolan-2-yl]amino]methylidene]amino]pentanoic acid

C21H35N9O15P2 (715.1727780000001)


   

(2S)-2-[[(4S)-4-[[(4S)-4-[[4-[(6aR)-3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl]benzoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid

(2S)-2-[[(4S)-4-[[(4S)-4-[[4-[(6aR)-3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl]benzoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid

C30H37N9O12 (715.2561562)


   

alpha-Neup5Ac-(2->6)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc

alpha-Neup5Ac-(2->6)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc

C27H45N3O19 (715.264714)


   

GlcNAc(b1-3)[NeuAc(a2-6)]GalNAc

GlcNAc(b1-3)[NeuAc(a2-6)]GalNAc

C27H45N3O19 (715.264714)


   

GalNAc(a1-3)[NeuAc(a2-6)]a-GalNAc

GalNAc(a1-3)[NeuAc(a2-6)]a-GalNAc

C27H45N3O19 (715.264714)


   

alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

C27H45N3O19 (715.264714)


   

GalNAc(a1-3)[NeuAc(a2-6)]GalNAc

GalNAc(a1-3)[NeuAc(a2-6)]GalNAc

C27H45N3O19 (715.264714)


   

alpha-Neup5Ac-(2->3)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc

alpha-Neup5Ac-(2->3)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc

C27H45N3O19 (715.264714)


   

9-deoxy-9-acetamido-alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine

9-deoxy-9-acetamido-alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine

C27H45N3O19 (715.264714)


   

NeuAc(a2-6)GlcNAc(b1-4)b-GlcNAc

NeuAc(a2-6)GlcNAc(b1-4)b-GlcNAc

C27H45N3O19 (715.264714)


   

NeuAc(a2-3)GalNAc(b1-4)GlcNAc

NeuAc(a2-3)GalNAc(b1-4)GlcNAc

C27H45N3O19 (715.264714)


   

NeuAc(a2-6)GalNAc(b1-4)GlcNAc

NeuAc(a2-6)GalNAc(b1-4)GlcNAc

C27H45N3O19 (715.264714)


   

GalNAc(b1-3)[NeuAc(a2-6)]GalNAc

GalNAc(b1-3)[NeuAc(a2-6)]GalNAc

C27H45N3O19 (715.264714)


   

GlcNAc(b1-4)GlcNAc(b1-4)NeuAc

GlcNAc(b1-4)GlcNAc(b1-4)NeuAc

C27H45N3O19 (715.264714)


   
   

Ifenprodil (tartrate)

Ifenprodil (tartrate)

C21H27NO2.1/2C4H6O6 (715.2206058)


Ifenprodil tartrate is a typical noncompetitive NMDA receptor antagonist. Ifenprodil tartrate exerts high affinity at NR1A/NR2B receptors (IC50=0.34 μM) over 400-fold than at NR1A/NR2A receptors (IC50=146 μM)[1]. Ifenprodil tartrate inhibits GIRK (Kir3), reduces inward currents through the basal GIRK activity. Ifenprodil tartrate has the potential to be a cerebral vasodilator[2]. Ifenprodil tartrate is a typical noncompetitive NMDA receptor antagonist. Ifenprodil tartrate exerts high affinity at NR1A/NR2B receptors (IC50=0.34 μM) over 400-fold than at NR1A/NR2A receptors (IC50=146 μM)[1]. Ifenprodil tartrate inhibits GIRK (Kir3), reduces inward currents through the basal GIRK activity. Ifenprodil tartrate has the potential to be a cerebral vasodilator[2].